Products

ACCESSOFF

One click!

accessoff.io Security & Privacy / Passwords & Identity

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$5/mo
Lower than 62% of peersNiche median $6.83/mo
Creators
Youssef Al Homsi
@accessoffio· 3 followers
Launched
2y ago
2024-08-27 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
X accounts@accessoffio
  • Launched on Product HuntLaunch

    Securely Share Without Sharing

    Aug 27, 2024 · 2y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2023-01-14

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Solo
Unknown
Sharing password-free access with 1 person
Starter
$ 5 per user/4 weeks
Professional
$ 12
Business
$ 15
Enterprise
Unknown

Trial: None · Enterprise custom tier · Observed 2026-11-07 · Source page

Entry price $5/mo, Lower than 62% of peers; “Passwords & Identity” median is $6.83/mo.View pricing benchmark

Website snapshots

Indexed 2024-08-27

Key pages

Desktop & mobile archive
Home
accessoff.io/ Snapshot 2026-11-08

Questions & evidence

How much does ACCESSOFF cost?
Solo: Unknown; Starter: $ 5 per user/4 weeks; Professional: $ 12; Business: $ 15; Enterprise: Unknown. Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does ACCESSOFF get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ACCESSOFF and what platforms does it support?
ACCESSOFF is catalogued under Passwords & Identity: One click! Supported platforms: Web.

Related products in this category

Security & Privacy / Passwords & Identity

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.